The ESMO Breast Cancer Virtual Meeting took place from 5–8 May 2021. Global experts in the breast cancer field came together online to present on the most recent advances, including updates from immunotherapy trials and the latest novel therapeutic targets.
longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively
Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC @AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725 @EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer
What a force @ZeynepZengin is! So proud of her for delivering such a fantastic talk about the role of liquid biopsies in guiding treatment selection in RCC. Learning from the best, of course! @montypal #EAU22 #RCC
The European School of Medical Oncology Breast Cancer Virtual Congress 2021
05–08 May 2021 | Virtual Meeting
The ESMO Breast Cancer Virtual Meeting took place from 5–8 May 2021. Global experts in the breast cancer field came together online to present on the most recent advances, including updates from immunotherapy trials and the latest novel therapeutic targets.
longer follow up (3 years) continues to show ctDNA is strongly associated with relapse (HR=6) and a 40% ⬇️ risk of death with atezo in adjuvant UC. There’s a strong rationale for circulating rather than tissue biomarkers here. Imvigor011 (randomised III) tests this prospectively
Last day at #EAU22, Outstanding plenary session and inspiring presentations on liquid biomarkers in #RCC @AStenzl @grantissimus @TurajlicLab @ZeynepZengin @srossi725 @EAUYAU_RenalCa @Uroweb @AmerUrological @KidneyCancer
What a force @ZeynepZengin is! So proud of her for delivering such a fantastic talk about the role of liquid biopsies in guiding treatment selection in RCC. Learning from the best, of course! @montypal #EAU22 #RCC
Leading experts Giuseppe Curigliano, Hope Rugo, Lisa Carey and Fatima Cardoso discuss the 2021 St. Gallen International Consensus Session and offer their perspectives on the optimal treatment of early breast cancer.